• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-2相关的线性IgA大疱性皮肤病

Interleukin-2 associated linear IgA bullous dermatosis.

作者信息

Tranvan A, Pezen D S, Medenica M, Michelson G C, Vogelzang N, Soltani K M

机构信息

Section of Dermatology, University of Chicago Medical Center, USA.

出版信息

J Am Acad Dermatol. 1996 Nov;35(5 Pt 2):865-7. doi: 10.1016/s0190-9622(96)90106-1.

DOI:10.1016/s0190-9622(96)90106-1
PMID:8912608
Abstract

Linear IgA bullous dermatosis (LABD) in adults is characterized by subepidermal bullae associated with a linear deposition of IgA at the basement membrane zone. Its cause is unclear, although it appears to have an immune-mediated basis. The development of LABD in a cancer patient undergoing immunotherapy has been described in the French literature. We describe a similar case of LABD arising in a patient while undergoing interleukin-2 immunotherapy for renal cell carcinoma.

摘要

成人线状IgA大疱性皮肤病(LABD)的特征是表皮下大疱,伴有IgA在基底膜带呈线状沉积。其病因尚不清楚,尽管似乎有免疫介导的基础。法国文献中曾描述过一名接受免疫治疗的癌症患者发生LABD的情况。我们描述了一名在接受白细胞介素-2免疫治疗肾细胞癌期间发生LABD的类似病例。

相似文献

1
Interleukin-2 associated linear IgA bullous dermatosis.白细胞介素-2相关的线性IgA大疱性皮肤病
J Am Acad Dermatol. 1996 Nov;35(5 Pt 2):865-7. doi: 10.1016/s0190-9622(96)90106-1.
2
Linear IgA bullous dermatosis induced by interferon-alpha 2a.
Clin Exp Dermatol. 2009 Jul;34(5):e123-4. doi: 10.1111/j.1365-2230.2008.03160.x.
3
Immunoelectronmicroscopic differentiation of linear IgA bullous dermatosis of adults with coexistence of IgA and IgG deposition from bullous pemphigoid.成人线状IgA大疱性皮肤病伴IgA和IgG沉积与大疱性类天疱疮的免疫电镜鉴别
J Am Acad Dermatol. 1992 Sep;27(3):394-9. doi: 10.1016/0190-9622(92)70205-t.
4
Drug-induced linear IgA bullous dermatosis probably induced by furosemide.药物性线状IgA大疱性皮肤病可能由速尿诱发。
J Am Acad Dermatol. 1999 Jul;41(1):103-5. doi: 10.1016/s0190-9622(99)70414-7.
5
Linear IgA bullous dermatosis in a patient with renal cell carcinoma.肾细胞癌患者的线状IgA大疱性皮肤病
Br J Dermatol. 2001 Apr;144(4):870-3. doi: 10.1046/j.1365-2133.2001.04148.x.
6
Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.
J Am Acad Dermatol. 1994 Feb;30(2 Pt 1):187-92. doi: 10.1016/s0190-9622(94)70015-x.
7
Linear IgA bullous dermatosis following influenza vaccination.流感疫苗接种后发生的线性IgA大疱性皮肤病
Dermatol Online J. 2009 Nov 15;15(11):3.
8
Naproxen-associated linear IgA bullous dermatosis: case report and review.萘普生相关的线状IgA大疱性皮肤病:病例报告及文献复习
Mayo Clin Proc. 2000 Sep;75(9):967-70. doi: 10.4065/75.9.967.
9
Linear IgA bullous dermatosis induced by atorvastatin.阿托伐他汀诱发的线状IgA大疱性皮肤病
J Am Acad Dermatol. 2001 Apr;44(4):689-92. doi: 10.1067/mjd.2001.113462.
10
[Bullous dermatosis with linear IgA deposits along the basement membrane during treatment with gamma interferon and interleukin-2].[γ干扰素和白细胞介素-2治疗期间沿基底膜有线性IgA沉积的大疱性皮肤病]
Ann Dermatol Venereol. 1990;117(11):899-902.

引用本文的文献

1
Tofacitinib for the treatment of severe rare skin diseases: a narrative review.托法替尼治疗严重罕见皮肤病:叙述性综述。
Eur J Clin Pharmacol. 2024 Apr;80(4):481-492. doi: 10.1007/s00228-024-03621-9. Epub 2024 Jan 17.
2
Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma.在一名治疗难治性转移性黑色素瘤患者中,由工程化白细胞介素2分子nemvaleukin alfa诱发的线性IgA大疱性皮肤病。
JAAD Case Rep. 2023 Sep 14;41:7-9. doi: 10.1016/j.jdcr.2023.08.040. eCollection 2023 Nov.
3
Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity.
老狗求新招:延迟性抗菌药物超敏反应诊断的当前实践与未来方向
Curr Opin Infect Dis. 2016 Dec;29(6):561-576. doi: 10.1097/QCO.0000000000000323.
4
Side effects of cytokines approved for therapy.已获批用于治疗的细胞因子的副作用。
Drug Saf. 2014 Nov;37(11):921-43. doi: 10.1007/s40264-014-0226-z.